BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31789307)

  • 21. Development and Validation of Web-Based Nomograms for Predicting Cause-Specific Mortality in Surgically Resected Nonmetastatic Invasive Breast Cancer: A Population-Based Study.
    Chen G; Jia M; Zeng Q; Zhang H
    Ann Surg Oncol; 2021 Oct; 28(11):6537-6550. PubMed ID: 34114183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database.
    Liu YL; Wang DW; Yang ZC; Ma R; Li Z; Suo W; Zhao Z; Li ZW
    Breast Cancer Res Treat; 2019 Nov; 178(2):379-388. PubMed ID: 31414242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
    Lin H; Wu Y; Liang G; Chen L
    PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
    BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.
    Shen K; Yao L; Wei J; Luo Z; Yu W; Zhai H; Wang J; Chen L; Fu D
    Cancer Med; 2019 Dec; 8(18):7890-7902. PubMed ID: 31663683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of Nomograms for Predicting Overall and Breast Cancer-Specific Survival in Young Women with Breast Cancer: A Population-Based Study.
    Gong Y; Ji P; Sun W; Jiang YZ; Hu X; Shao ZM
    Transl Oncol; 2018 Dec; 11(6):1334-1342. PubMed ID: 30189361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours.
    Song W; Lv CG; Miao DL; Zhu ZG; Wu Q; Wang YG; Chen L
    Eur J Surg Oncol; 2018 Oct; 44(10):1657-1665. PubMed ID: 30082175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.
    Gao J; Wang S; Li F; Xu H; Li X; Yan L; Zhu L
    Adv Ther; 2022 Jan; 39(1):257-285. PubMed ID: 34716558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
    Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
    Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
    Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
    BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
    Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
    Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
    Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
    Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of breast-conserving surgery without radiotherapy and mastectomy in the treatment of elderly patients with early breast cancer: A PSM and SEER database study.
    Fu B; Chen X; Liang W; Wang Y; Yao Y; Zhang J
    Cancer Med; 2023 Jul; 12(14):15229-15245. PubMed ID: 37269188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.
    Cui X; Song D; Li X
    Front Oncol; 2020; 10():636549. PubMed ID: 33628740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
    Jiang AG; Cai X
    BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: A retrospective cohort study.
    Zhou W; Huang C; Yuan N
    Int J Surg; 2018 Dec; 60():28-40. PubMed ID: 30389534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.
    Lan LF; Gao CK; Ma CW
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):359-368. PubMed ID: 32692284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a nomogram to individually predict survival of young patients with nonmetastatic gastric cancer: A retrospective cohort study.
    Wu C; Wang N; Zhou H; Wang T; Zhao D
    Saudi J Gastroenterol; 2019; 25(4):236-244. PubMed ID: 30719999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
    Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
    BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.